Teladoc Health Appoints Michael Grasher as Chief Financial Officer

Rhea-AI Summary

Teladoc Health (NYSE: TDOC) has appointed Michael Grasher as Chief Financial Officer, effective immediately. Grasher brings more than three decades of experience in insurance and financial services, including over 12 years in CFO roles at public and private companies.

He most recently served as CFO of IFG Companies and previously held CFO and Executive Vice President positions at Fortegra and AMERISAFE. Earlier in his career, he spent over a decade in equity research, including as a Managing Director at Piper Jaffray. According to Teladoc Health, his background in financial stewardship, operational discipline and strategy is expected to support the company’s focus on disciplined, sustainable growth.

Positive

• New CFO appointed with more than 30 years of financial experience
• Over 12 years of prior CFO roles at public and private companies
• Background includes CFO roles at IFG Companies, Fortegra and AMERISAFE
• Additional experience as equity research analyst and Managing Director at Piper Jaffray

Negative

• None.

Market Context

The CFO appointment can be evaluated against TDOC’s Net Selling insider sentiment over 90 days and t...

Analysis

The CFO appointment can be evaluated against TDOC’s Net Selling insider sentiment over 90 days and the prior 0.45% response to a board appointment. That context adds governance and execution considerations; subsequent filings remain relevant.

Key Figures

Industry experience: more than three decades CFO experience: more than 12 years Equity research experience: more than a decade

3 metrics

Industry experience more than three decades Michael Grasher’s insurance and financial services career

CFO experience more than 12 years CFO roles at public and privately held companies

Equity research experience more than a decade Buy-side and sell-side analyst career

Historical Context

4 past events · Latest: Aug 03 (Positive)

Pattern 4 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 03	Board appointment	Positive	+0.5%	Financial executive joined board and audit and compensation committees
Jul 29	Q2 earnings report	Negative	-28.3%	Revenue declined and quarterly net loss reached $38.9 million
Jul 15	Earnings scheduling	Neutral	-2.6%	Company scheduled Q2 2026 results release for July 29
Jul 03	Inducement award	Neutral	+1.0%	New BetterHelp product head received 50,000 restricted stock units

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

TDOC’s prior management announcements were followed by small positive reactions, while its Q2 earnings report was followed by a -28.32% reaction.

Key Terms

equity research, buy-side, sell-side

3 terms

equity research financial

"Before moving into corporate finance leadership, he spent more than a decade in equity research"

Equity research is the process of studying a publicly traded company's business, finances and market position to form an informed view on whether its stock is a good investment. Think of it as a detailed inspection and forecast — analysts gather facts, estimate future profits and risks, and then recommend buy, hold or sell; investors use these findings like a weather report to judge potential returns and risks before putting money into a stock.

buy-side financial

"as both a buy- and sell-side analyst"

Buy-side describes firms and professionals whose job is to purchase securities and other assets on behalf of clients or for their own investment portfolios, such as mutual funds, pension funds, hedge funds, and asset managers. It matters to investors because buy-side activity drives demand, influences prices and market trends—think of them as the large shoppers whose buying choices can move the market and signal which investments are in favor.

sell-side financial

"as both a buy- and sell-side analyst"

Sell-side describes financial firms and professionals—such as broker-dealers, investment banks and analysts—whose job is to create, promote and sell securities and related services to other market participants. They publish research, make markets and execute trades much like shopkeepers who stock, advertise and sell goods; their reports and trading activity can shape prices, liquidity and investor access, so investors watch sell-side output to help judge market signals and opportunities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth 

NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Grasher as Chief Financial Officer, effective immediately.

Mr. Grasher is an accomplished financial executive with more than three decades of experience across the insurance and financial services sectors, including more than 12 years in CFO roles at public and privately held companies.

He most recently served as CFO of IFG Companies, a privately held property-casualty insurance organization, where he was responsible for financial reporting, planning and analysis, and treasury management. Previously, Mr. Grasher served as CFO and Executive Vice President of Fortegra, a global specialty insurer, overseeing financial governance and accounting across U.S. and European operations, among other duties. Prior to Fortegra, he served as CFO and Executive Vice President of AMERISAFE, a publicly traded specialty provider of workers’ compensation insurance, where he led financial reporting, capital management and investor relations. Before moving into corporate finance leadership, he spent more than a decade in equity research as both a buy- and sell-side analyst, including as a Managing Director at Piper Jaffray, now Piper Sandler.

“Mike is an experienced financial leader with a proven record of financial stewardship, driving operational discipline and strategic execution,” said Chuck Divita, Chief Executive Officer of Teladoc Health. “Mike’s combination of public company experience, financial leadership and operating discipline will be particularly valuable as we continue to strengthen the business, execute our strategic priorities and deliver long-term value for our stakeholders.”

Throughout his career, Mr. Grasher has supported sustained growth, profitability and corporate strategy across the companies he has served and brings experience leading enterprise-wide efficiency initiatives and shaping long-term strategy.

“Teladoc Health has built a strong foundation with unmatched scale, deep clinical expertise and a global footprint,” said Grasher. “I’m excited to work with Chuck and the leadership team to build on that foundation and deliver lasting value for the members, clients and shareholders we serve.”

About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms and partners —transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Investors:
Michael Minchak
617-444-9612
ir@teladochealth.com

Media:
Lou Serio
202-569-9715
pr@teladochealth.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/642c837e-ba21-4636-9b33-efb5724b5398

FAQ

Who is the new CFO of Teladoc Health (NYSE: TDOC) as of August 31, 2026?

Teladoc Health appointed Michael Grasher as Chief Financial Officer effective August 31, 2026. According to Teladoc Health, he brings more than three decades of financial experience, including over 12 years in CFO roles at public and privately held companies.

What is Michael Grasher’s professional background before joining Teladoc Health (TDOC) as CFO?

Michael Grasher previously served as CFO of IFG Companies, and earlier as CFO and Executive Vice President at Fortegra and AMERISAFE. According to Teladoc Health, he also spent over a decade in equity research, including as a Managing Director at Piper Jaffray.

Why did Teladoc Health (TDOC) appoint Michael Grasher as CFO in 2026?

Teladoc Health appointed Michael Grasher for his experience in financial stewardship, operational discipline and strategic execution. According to Teladoc Health, his combination of public company CFO experience and operating discipline aligns with the company’s strategy of disciplined, sustainable growth and long-term value creation.

What sectors has Teladoc Health’s new CFO Michael Grasher worked in before joining TDOC?

Michael Grasher has worked primarily in the insurance and financial services sectors. According to Teladoc Health, his background includes senior financial roles at property-casualty and specialty insurers and significant experience in equity research covering financial companies.

How much CFO experience does Michael Grasher have before taking the Teladoc Health (TDOC) role?

Michael Grasher has more than 12 years of experience in CFO roles. According to Teladoc Health, these roles span both public and privately held companies, including IFG Companies, Fortegra and AMERISAFE, complementing over three decades in financial services overall.

What are Teladoc Health’s expectations for Michael Grasher as CFO of TDOC?

Teladoc Health expects Michael Grasher to support disciplined, sustainable growth and strategic execution. According to Teladoc Health, his experience in financial governance, capital management and enterprise-wide efficiency initiatives is viewed as important to strengthening the business and delivering long-term stakeholder value.